462
Views
36
CrossRef citations to date
0
Altmetric
Articles

During apoptosis HMGB1 is translocated into apoptotic cell-derived membraneous vesicles

, , , , , & show all
Pages 342-346 | Received 12 Nov 2012, Accepted 12 Nov 2012, Published online: 17 Jan 2013

References

  • Bruhn S. L., Pil P. M., Essigmann J. M., Housman D. E., Lippard S. J.. Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl. Acad. Sci. USA. 1992; 89 6: 2307–2311.
  • Teo S. H., Grasser K. D., Thomas J. O.. Differences in the DNA-binding properties of the HMG-box domains of HMG1 and the sex-determining factor SRY. Eur. J. Biochem.. 1995; 230 3: 943–950.
  • Youn J. H., Shin J. S.. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol.. 2006; 177 11: 7889–7897.
  • Scaffidi P., Misteli T., Bianchi M. E.. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002; 418 6894: 191–195.
  • Gauley J., Pisetsky D. S.. The translocation of HMGB1 during cell activation and cell death. Autoimmunity. 2009; 42 4: 299–301.
  • Bianchi M. E., Manfredi A. A.. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev.. 2007; 220:35–46.
  • Schiraldi M., Raucci A., Munoz L. M., . HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med.. 2012; 209 3: 551–563.
  • Wu C. X., Sun H., Liu Q., Guo H., Gong J. P.. LPS Induces HMGB1 Relocation and Release by Activating the NF-kappaB-CBP Signal Transduction Pathway in the Murine Macrophage-Like Cell Line RAW264.7. J. Surg. Res.. 2012; 175 1: 88–100.
  • Voll R. E., Herrmann M., Roth E. A., . Immunosuppressive effects of apoptotic cells. Nature. 1997; 390 6658: 350–351.
  • Sebbagh M., Renvoize C., Hamelin J., . Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell. Biol.. 2001; 3 4: 346–352.
  • Sebbagh M., Hamelin J., Bertoglio J., Solary E., Breard J.. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J. Exp. Med.. 2005; 201 3: 465–471.
  • Distler J. H., Huber L. C., Gay S., Distler O., Pisetsky D. S.. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity. 2006; 39 8: 683–690.
  • Schiller M., Bekeredjian-Ding I., Heyder P., . Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ.. 2008; 15 1: 183–191.
  • Fransen J. H., Hilbrands L. B., Ruben J., . Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum.. 2009; 60 8: 2304–2313.
  • Pisetsky D. S., Lipsky P. E.. Microparticles as autoadjuvants in the pathogenesis of SLE. Nat. Rev. Rheumatol.. 2010; 6 6: 368–372.
  • Fehr E. M., Spoerl S., Heyder P., . Apoptotic-cell-derived membrane vesicles induce an alternative maturation of human dendritic cells which is disturbed in SLE. J. Autoimmun.. 2012 2012 Sep 29. doi:pii: S0896-8411(12)00123-0.10.1016.
  • Schiller M., Parcina M., Heyder P., . Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles. J. Immunol.. 2012; 189 4: 1747–1756.
  • Fransen J. H., Hilbrands L. B., Jacobs C. W., . Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity. 2009; 42 4: 325–327.
  • Ling Z. L., Combes V., Grau G. E., King N. J.. Microparticles as immune regulators in infectious disease — An opinion. Front Immunol.. 2011; 2:67.
  • Fehr E. M., Kierschke S., Max R., . Apototic cell-derived membrane vesicles induce CD83 expression on human mdDC. Autoimmunity. 2009; 42 4: 322–324.
  • Heyder P., Bekeredjian-Ding I., Parcina M., . Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha. Autoimmunity. 2007; 40 4: 331–332.
  • Pisetsky D. S., Ullal A. J., Gauley J., Ning T. C.. Microparticles as mediators and biomarkers of rheumatic disease. Rheumatology (Oxford). 2012; 51 10: 1737–1746.
  • Fransen J. H., Berden J. H., Koeter C. M., . Effect of administration of apoptotic blebs on disease development in lupus mice. Autoimmunity. 2012; 45 4: 290–297.
  • Meesmann H. M., Parcina M., Lorenz H. M., Blank N., Schiller M.. Apo material as a trigger for inflammation in systemic lupus erythematosus. Autoimmunity. 2009; 42 4: 251–253.
  • Bilyy R., Nemesh L., Antonyuk V., . Apoptosis-related changes in plasma membrane glycoconjugates of peripheral blood lymphocytes in rheumatoid arthritis. Autoimmunity. 2009; 42 4: 334–336.
  • Park D., Tosello-Trampont A. C., Elliott M. R., . BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature. 2007; 450 7168: 430–434.
  • Miyanishi M., Tada K., Koike M., . Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007; 450 7168: 435–439.
  • Meesmann H. M., Fehr E. M., Kierschke S., . Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes. J. Cell Sci.. 2010; 123 Pt 19: 3347–3356.
  • Franz S., Herrmann K., Fuhrnrohr B., . After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ.. 2007; 14 4: 733–742.
  • Radic M., Marion T., Monestier M.. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol.. 2004; 172 11: 6692–6700.
  • Miguet L., Pacaud K., Felden C., . Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics. 2006; 6 1: 153–171.
  • Urbonaviciute V., Furnrohr B. G., Meister S., . Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med.. 2008; 205 13: 3007–3018.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.